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Abstract
Background. The aim of the present study was to evaluate the feasibility and efficacy of the LigaSure vessel sealing system on
a large scale when used for liver resection. Methods. We retrospectively analyzed the short-term outcomes of 277 patients
undergoing hepatectomies with the use of the LigaSureR system. Results. There were two hospital deaths (0.7%), and the
morbidity rate was 25.3%. Mean blood loss during liver transection was 3529422 ml, and the liver transection speed was
1.990.86 cm2/min. The number of ties required during liver transection was 13.2913. The morbidity and mortality rate
was similar when comparing patients with injured livers (chronic hepatitis or cirrhosis) and those with normal livers, but
liver transection speed was faster in those with normal livers when compared with those with injured livers (2.0090.88 vs.
1.5790.63 cm2/min, p0.001). Conclusions. The LigaSure system can be applied safely in patients undergoing liver
resection, regardless of whether cirrhosis is present or not.
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Introduction
Surgical techniques for liver resection have improved
dramatically over the past two decades [13]. Various
studies have demonstrated that the postoperative
morbidity and mortality for patients undergoing liver
resection is closely related to the degree of intrao-
perative blood loss, the majority of which occurs
during transection of the liver parenchyma [46].
Therefore, the particulars of the technique employed
for liver transection are critical for optimal outcomes.
Several techniques have been employed to reduce
intraoperative blood loss during liver resection. The
Pringle maneuver is the most widely accepted techni-
que to achieve bloodless hepatectomy [4,7]. Recently,
randomized controlled trial showed that intraopera-
tive blood salvage was effective in reducing intrao-
perative blood loss [8]. The cavitational ultrasonic
surgical aspirator (CUSA) has also been used to
facilitate bloodless hepatectomy, but a randomized
clinical trial comparing ultrasonic and manual clamp
transection of the liver showed no difference in blood
loss and operation time [9]. The crush clamping
method is another simple and widely adopted techni-
que used during liver transection, and Lesurtel and
colleagues reported that the crush clamping technique
was superior in terms of resection time, blood loss,
and blood transfusion frequency when compared with
the CUSA, Hydrojet, and dissecting sealers [10].
The LigaSure Vessel Sealing System (Valleylab,
Boulder, CO, USA) is a novel hemostatic device
that can seal blood vessels up to 7 mm in diameter by
denaturing collagen and elastin within the vessel wall
and in the surrounding connective tissue. In a
randomized clinical trial, the use of LigaSure system
reduced operation time and blood loss in patients
undergoing hemorrhoidectomy and gastrectomy
[1113]. We previously reported that the use of
LigaSure plus crush clamping during liver resection
allowed rapid and safe division of the liver parench-
yma [8].
The goal of the present study was to analyze the
safety and efficacy of the LigaSure sealing system
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Institute Hospital (Tokyo, Japan). The Patients who
underwent liver resection with concomitant lymph
node dissection or bile duct reconstruction and those
who underwent laparoscopic liver resection were
excluded from this study. Thus, data from a total of
277 patients (87.9%) who underwent liver resection
using the LigaSure system were analyzed for this
study.
Analysis
Prospectively collected data were retrospectively ana-
lyzed. Intraoperative data, including operative time
(min), liver transection time (min), liver transection
area (cm2), portal triad clamp time (Pringle time;
min), estimated blood loss during liver transection
and operation (ml), central venous pressure (cm
H2O) and total number of ligations during liver
transection, were recorded for subsequent analysis.
The estimated blood loss during liver transection was
calculated as total blood loss minus the estimated
blood loss before the liver transection. The transec-
tion speed (cm2/min) was calculated as transection
area divided by transection time. The maximum
tumor size, tumor number, type of hepatectomy,
concomitant resection, and preoperative liver status
(normal or injured) were recorded. Minor hepatect-
omy was defined as limited resection of two or less
Couinaud segments, and major hepatectomy as resec-
tion of three or more Couinaud segments. Injured
liver was defined as chronic hepatitis or cirrhosis in
pathological findings of the resected specimen. Post-
operative variables were analyzed and included com-
plications, length of hospital stay (days), and
mortality. Operative mortality was defined as any
death resulting from a complication during operation.
Surgical technique
All operations in this study were performed or
supervised by two senior surgeons (Yamamoto J and
Saiura A). After laparotomy by J incision, the whole
liver was examined by intraoperative ultrasonography.
Liver transection was performed using a crush clamp-
ing technique and an intermittent Pringle maneuver
with periods of 15 minutes of clamping and 5 minutes
of unclamping (Figure 1). The liver transection was
accomplished in three steps. First, the liver parench-
yma was crushed using Kelly forceps (Figure 1A) and
then aspirated, revealing the residual vessels or
Glissonian sheaths. Second, the residual tissue was
sealed using the LigaSure Standard handset (Figure
1B,C) at a power level of 2. Glissonian sheaths or
hepatic veins of diameter 3 mm were ligated with
40 Vicryl (Ethicon, CO, USA) (Figure 2). Finally,
the center of the sealed zone was divided with scissors
(Figure 1D), and electric cautery was used to seal the
remaining tissue. No clips were used. The bile leak
test was performed routinely after liver transection.
Statistical analysis
Quantitative variables were compared using student
t-test. Comparisons between groups were performed
using the Chi-square test. Statistical analyses were
conducted using a statistical analysis package (SPSS
9.0, SPSS Inc., Chicago, IL). A pvalue B0.05 was
considered to represent statistical significance.
Results
Clinical data from 277 patients were analyzed. The
mean age of the patients was 63.4910.6 (years9SD).
One hundred seventy-seven males and 100 females
were included. Cause of disease was metastatic liver
tumor (n188), primary liver carcinoma (n72),
and various benign conditions (n17). Histological
examination of resected liver showed normal liver in
233 patients (84%) and chronic liver disease or
cirrhosis in 44 patients (16%). Major hepatectomy
was performed in 71 patients (25%), and minor
hepatectomy was performed in 206 patients (75%).
In patients with synchronous metastases arising from
gastrointestinal malignancy, liver resection was per-
formed synchronously after resection of the primary
tumor. Combined gastrointestinal resection was per-
formed synchronously in 41 patients (14%; colorectal,
n24; stomach, n17) prior to liver resection. Eight
patients (2.8%) required hepatic vein reconstruction
due to metastatic invasion from a primary colorectal
cancer. The maximum diameter of resected tumor
was 4.092.9 (mean9SD) cm, with solitary tumors in
160 patients (57%) and multiple tumors in 117
patients (43%).
Fifty-three repeat hepatectomies (19%) were in-
cluded. The mean amount of blood loss during
operation and during liver transection was 6309652
ml and 3529422 ml, respectively. The mean liver
transection speed and transection area was 1.939
0.86 cm2/min and 74.0950.2 cm2, respectively. The
mean number of ties required during liver transection
was 13.2913. The mean central venous pressure was
5.392.7 cm H2O. The mortality and morbidity rate
was 0.7 and 25.2%, respectively. Two patients died
due to massive hemorrhage (first postoperative day)
and liver failure (59th postoperative day), respectively.
The mean postoperative hospital stay was 16.7911.3
days. The incidence of bile leak was 5.7% (n16),
but all bile leaks resolved spontaneously. Other
complications included pleural or ascites (n21,
7.5%), wound infection (n11, 3.9%), postoperative
hemorrhage (n3, 1.0%), sepsis (n3, 1.0%), ileus
(n2, 0.7%), liver failure (n2, 0.7%) and various
others (n10, 3.6%).
Preoperative status included 233 patients with
normal livers and 44 patients with injured livers
(Table I). There were two hospital deaths in the
normal liver group. The morbidity rate was similar in
both groups (23% vs. 31%, p0.252). The amount
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of blood loss during liver transection and the transec-
tion area was similar in both groups. However, the
liver transection speed was significantly greater in the
normal liver group than in the injured liver group
(2.00 cm2/min vs. 1.57 cm2/min, p0.001). The total
number of ties required during liver transection was
similar when comparing the two groups.
Discussion
The present study investigated the short-term out-
comes for patients undergoing liver resection with the
use of the LigaSure system and the crush clamping
method. A previous randomized controlled study of
60 patients demonstrated that a faster and equally safe
hepatectomy was achieved with the LigaSure system
when compared with the crush clamping method
without the use of the LigaSure system. The present
study confirmed these findings in a larger patient
population, with the exception that there were two
hospital deaths. One patient died on the first post-
operative day due to massive intraoperative hemor-
rhage secondary to tearing of middle hepatic vein in
the context of a metastatic lesion located at the root of
the middle hepatic vein. This patient had undergone
hepatectomy on three prior occasions secondary to
recurrent colorectal metastases. The second patient
died on the 59th postoperative day due to post-
operative liver failure. This patient had undergone
hepatectomy once before secondary to colorectal liver
Figure 1. Crush clamping method with the LigaSure system. (A) Crushing of the liver parenchyma using Kelly forceps. (B,C) Sealing the
residual tissue using the LigaSure system. (D) Dividing the center of the sealed zone.
Figure 2. The raw surface was shown. The Glissonian sheath of
segment 3 was ligated.
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metastases. In both the cases, the LigaSure system did
not seem directly related to the mechanism of death.
The LigaSure system has been used in many
surgical procedures. A reduction in intraoperative
blood loss and a shortening of operation duration
were determined in various operation. Previous stu-
dies have reported that the LigaSure system may
present some technical difficulties when sealing the
bile duct [14]. In this study, bile ducts in the portal
tract of less than B3 mm in diameter were success-
fully sealed with the LigaSure system, and the
incidence of bile leak was 5.7%, which is consistent
with previous studies and which suggests that even
thin bile ducts in the minor portal tract can be sealed
safely by this device [15,16]. However, our experience
suggests that it may be difficult to seal very small
vessels with the LigaSure system. Thus, tiny Glisso-
nian sheaths directly originated from main trunk such
as Glissonian sheeths of the caudate lobe should be
ligated with conventional techniques.
Romano and colleagues reported that the LigaSure
system was unable to achieve hemostasis in patients
with cirrhotic liver disease undergoing liver transec-
tion. In our study, blood loss during liver transection
was similar when comparing patients with normal
livers and those with injured livers. However, Roma-
no’s study did not use routine inflow occlusion, and
the present study utilized the Pringle maneuver
routinely. Further, the liver parenchyma was crushed
by means of the LigaSure forceps in Romano’s study
rather than the Kelly forceps employed in the present
study. Thus, the techniques used in the present study
appear to be superior in terms of achieving hemostasis
in patients with cirrhosis. However, the slower trans-
ection speed for patients with injured livers in the
present study may reflect a more meticulous liver
transection that could have promoted the high rate of
successful hemostasis.
LigaSure can be applied safely in any type of liver
and hepatectomy when used with the crush clamping
method. Therefore, we think that any hepatic surgeon
skilled in the crush clamping method can use the
LigaSure system to achieve faster liver transection.
However, the sharp tip of the LigaSure forceps can
damage small vessels and lead to a hemorrhage. The
shape of the LigaSure forceps needs to be improved.
The LigaSure disposable hand piece (LigaSure
Standard) used in Japan costs approximately $150
USD per unit. However, the LigaSure system reduced
the length of time required for hepatectomy by
11 minutes and reduced the length of time to
hemostasis after hepatectomy, thereby reducing total
operative time by 30 minutes. These properties likely
result in a favorable costbenefit analysis for this
system.
In conclusion, the LigaSure system can be applied
safely in patients undergoing liver resection, regard-
less of whether cirrhosis is present or not.
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